Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

Published Feb 14, 2020

Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

A study designed to rule out heart-risk found a slightly higher incidence of cancer among those who took the drug for one year.

NOW
PLAYING
Chemotherapy Side Effects: Nausea and Vomiting
NOW
PLAYING
What You Think about Chemotherapy May Be Wrong
NOW
PLAYING
Ovarian Cancer - New PARP Inhibitor Combination Drug Approval
NOW
PLAYING
The IV Chemotherapy Experience for Ovarian Cancer Patients
NOW
PLAYING
When to Add PARP Inhibitors to Your Ovarian Cancer Treatment
NOW
PLAYING
PARP Inhibitor Side Effects
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.